ARGATROBAN

Course overview

ARGATROBAN IS A MEDICATION USED IN THE MANAGEMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT), WHICH IS A RARE, LIFE-THREATENING COMPLICATION OF HEPARIN THERAPY. IT IS A DIRECT THROMBIN INHIBITOR, A CLASS OF ANTICOAGULANT DRUGS. THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR ARGATROBAN AS A VALUABLE AGENT IN THE PROPHYLAXIS AND TREATMENT OF THROMBOSIS IN PATIENTS WITH HIT. THIS ACTIVITY ALSO HIGHLIGHTS THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA.